Latest Breaking News On - Lupin pharmaceuticals inc - Page 1 : comparemela.com

Dyspnea Treatment Market Forecast: USD 12.2 Billion by 2033

Market OverviewThe projected growth of the Global Dyspnea Treatment Market from USD 6.3 billion in 2023 to USD 12.2 billion by 2033, at a compound annual growth rate (CAGR) of 6.8%, reflects increasing demand for treatments addressing dyspnea a common symptom associated with various respiratory diseases, heart condi.

United-states
New-york
America
Asia-pacific
Lupin-pharmaceuticals-inc
Market-companies
Boehringer-ingelheim-international-gmb
Bausch-health-companies-inc
Glaxosmithkline
Nephron-pharmaceuticals-corporation
Route-of-administration
Porter-five-forces-analysis

Global Xerostomia Therapeutics Analysis & Forecast to

Global Xerostomia Therapeutics Analysis & Forecast to
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Australia
Japan
Russia
Argentina
China
Italy
South-korea
Brazil
India
Spain
Germany
United-states

Nisa Godrej to Yashasvini Jindal: 10 lesser-known daughters of Indian billionaires making waves in the business world

Nisa Godrej to Yashasvini Jindal: 10 lesser-known daughters of Indian billionaires making waves in the business world
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Vinita-gupta
Lupin-pharmaceuticals-inc
Leading-lupin-pharmaceuticals-inc

Lupin, Glenmark recall drugs in US market: USFDA

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market.

India
United-states
Aurangabad
Maharashtra
Australia
Japan
American
Natco-pharma
Kothur-telangana
Lupin-pharmaceuticals-inc
Drug-administration
Glenmark-pharmaceuticals-inc

Lupin, Glenmark and Natco Pharma recall drugs in US market due to manufacturing issues

Lupin, Glenmark and Natco Pharma recall drugs in US market due to manufacturing issues
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India
Japan
Australia
United-states
Aurangabad
Maharashtra
American
Natco-pharma
Kothur-telangana
Glenmark-pharmaceuticals-inc
Drug-administration
Lupin-pharmaceuticals-inc